Review



recombinant non structural protein 1 ns1 protein  (Native Antigen Inc)


Bioz Verified Symbol Native Antigen Inc is a verified supplier
Bioz Manufacturer Symbol Native Antigen Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Native Antigen Inc recombinant non structural protein 1 ns1 protein
    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c <t>NS1-specific</t> IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.
    Recombinant Non Structural Protein 1 Ns1 Protein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant non structural protein 1 ns1 protein/product/Native Antigen Inc
    Average 86 stars, based on 1 article reviews
    recombinant non structural protein 1 ns1 protein - by Bioz Stars, 2026-06
    86/100 stars

    Images

    1) Product Images from "An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques"

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    Journal: NPJ Vaccines

    doi: 10.1038/s41541-020-0167-8

    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.
    Figure Legend Snippet: a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.

    Techniques Used: Enzyme-linked Immunosorbent Assay

    a Env-specific memory B-cell ELISpot results, b NS1-specific memory B-cell ELISpot results at baseline, day 90 and day 164 following IM vaccination of cynomolgus macaques with 100, 200, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28. Bar = Geometric mean. (ANOVA *** P -value < 0.001). Dotted line = responder cutoff.
    Figure Legend Snippet: a Env-specific memory B-cell ELISpot results, b NS1-specific memory B-cell ELISpot results at baseline, day 90 and day 164 following IM vaccination of cynomolgus macaques with 100, 200, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28. Bar = Geometric mean. (ANOVA *** P -value < 0.001). Dotted line = responder cutoff.

    Techniques Used: Enzyme-linked Immunospot

    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN50) titers, and c NS1-specific IgG ELISA titers following IM vaccination of cynomolgus macaques with ZPIV-SP 100 AU on day 0, day 28, and a booster on day 176. ANOVA ** P -value < 0.01. Horizontal dotted lines = limit of quantification. Arrows = vaccination on D0, D28, and boost. Vertical dotted line = boosting dose (D176).
    Figure Legend Snippet: a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN50) titers, and c NS1-specific IgG ELISA titers following IM vaccination of cynomolgus macaques with ZPIV-SP 100 AU on day 0, day 28, and a booster on day 176. ANOVA ** P -value < 0.01. Horizontal dotted lines = limit of quantification. Arrows = vaccination on D0, D28, and boost. Vertical dotted line = boosting dose (D176).

    Techniques Used: Enzyme-linked Immunosorbent Assay

    a Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following challenge of cynomolgus macaques ( n = 6/group) on day 176 by the SC route with 10 5 PFU of PRVABC59 wt-ZIKA strain. (ANOVA ** P -value < 0.01; *** P -value < 0.001). Dotted line = limit of quantification.
    Figure Legend Snippet: a Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following challenge of cynomolgus macaques ( n = 6/group) on day 176 by the SC route with 10 5 PFU of PRVABC59 wt-ZIKA strain. (ANOVA ** P -value < 0.01; *** P -value < 0.001). Dotted line = limit of quantification.

    Techniques Used: Enzyme-linked Immunosorbent Assay

    a prM/Env-specific memory B-cell ELISpot responses, b NS1-specific memory B-cell ELISpot responses at baseline, day 35 and day 112 following ZIKV challenge in cynomolgus macaques with 10 5 PFU of PRVABC59 wt-ZIKA strain. Bar = Geometric mean. (ANOVA * P -value < 0.05; ** P -value < 0.01; *** P -value < 0.001). Dotted line = responder cutoff. p.c. = post-challenge.
    Figure Legend Snippet: a prM/Env-specific memory B-cell ELISpot responses, b NS1-specific memory B-cell ELISpot responses at baseline, day 35 and day 112 following ZIKV challenge in cynomolgus macaques with 10 5 PFU of PRVABC59 wt-ZIKA strain. Bar = Geometric mean. (ANOVA * P -value < 0.05; ** P -value < 0.01; *** P -value < 0.001). Dotted line = responder cutoff. p.c. = post-challenge.

    Techniques Used: Enzyme-linked Immunospot



    Similar Products

    recombinant yellow fever virus yfv non structural protein 1  (R&D Systems)
    93
    R&D Systems recombinant yellow fever virus yfv non structural protein 1
    Recombinant Yellow Fever Virus Yfv Non Structural Protein 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant yellow fever virus yfv non structural protein 1/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant yellow fever virus yfv non structural protein 1 - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    recombinant dengue virus non structural 1 ns1 protein  (Abcam)
    99
    Abcam recombinant dengue virus non structural 1 ns1 protein
    Recombinant Dengue Virus Non Structural 1 Ns1 Protein, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant dengue virus non structural 1 ns1 protein/product/Abcam
    Average 99 stars, based on 1 article reviews
    recombinant dengue virus non structural 1 ns1 protein - by Bioz Stars, 2026-06
    99/100 stars
    		  Buy from Supplier
    recombinant non structural protein 1 ns1 protein  (Native Antigen Inc)
    86
    Native Antigen Inc recombinant non structural protein 1 ns1 protein
    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c <t>NS1-specific</t> IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.
    Recombinant Non Structural Protein 1 Ns1 Protein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant non structural protein 1 ns1 protein/product/Native Antigen Inc
    Average 86 stars, based on 1 article reviews
    recombinant non structural protein 1 ns1 protein - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.

    Journal: NPJ Vaccines

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    doi: 10.1038/s41541-020-0167-8

    Figure Lengend Snippet: a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following IM vaccination of six cynomolgus macaques with each dose: 100 AU, 200 AU, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28 (ANOVA * P -value < 0.05; *** P -value < 0.001). Dotted lines: limit of quantification. Arrows: vaccination on D0 and D28.

    Article Snippet: Envelope- and NS1-specific IgGs were assessed by ELISA in 96-well plates coated with recombinant E protein (Meridian Life Science Inc., Memphis, USA) or recombinant non-structural protein 1 (NS1) protein (Native Antigen Company, Oxford, UK) in carbonate buffer, pH 9.6.

    Techniques: Enzyme-linked Immunosorbent Assay

    a Env-specific memory B-cell ELISpot results, b NS1-specific memory B-cell ELISpot results at baseline, day 90 and day 164 following IM vaccination of cynomolgus macaques with 100, 200, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28. Bar = Geometric mean. (ANOVA *** P -value < 0.001). Dotted line = responder cutoff.

    Journal: NPJ Vaccines

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    doi: 10.1038/s41541-020-0167-8

    Figure Lengend Snippet: a Env-specific memory B-cell ELISpot results, b NS1-specific memory B-cell ELISpot results at baseline, day 90 and day 164 following IM vaccination of cynomolgus macaques with 100, 200, or 400 AU of ZPIV-SP or 200 AU of ZPIV on day 0 and day 28. Bar = Geometric mean. (ANOVA *** P -value < 0.001). Dotted line = responder cutoff.

    Article Snippet: Envelope- and NS1-specific IgGs were assessed by ELISA in 96-well plates coated with recombinant E protein (Meridian Life Science Inc., Memphis, USA) or recombinant non-structural protein 1 (NS1) protein (Native Antigen Company, Oxford, UK) in carbonate buffer, pH 9.6.

    Techniques: Enzyme-linked Immunospot

    a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN50) titers, and c NS1-specific IgG ELISA titers following IM vaccination of cynomolgus macaques with ZPIV-SP 100 AU on day 0, day 28, and a booster on day 176. ANOVA ** P -value < 0.01. Horizontal dotted lines = limit of quantification. Arrows = vaccination on D0, D28, and boost. Vertical dotted line = boosting dose (D176).

    Journal: NPJ Vaccines

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    doi: 10.1038/s41541-020-0167-8

    Figure Lengend Snippet: a ZIKV Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN50) titers, and c NS1-specific IgG ELISA titers following IM vaccination of cynomolgus macaques with ZPIV-SP 100 AU on day 0, day 28, and a booster on day 176. ANOVA ** P -value < 0.01. Horizontal dotted lines = limit of quantification. Arrows = vaccination on D0, D28, and boost. Vertical dotted line = boosting dose (D176).

    Article Snippet: Envelope- and NS1-specific IgGs were assessed by ELISA in 96-well plates coated with recombinant E protein (Meridian Life Science Inc., Memphis, USA) or recombinant non-structural protein 1 (NS1) protein (Native Antigen Company, Oxford, UK) in carbonate buffer, pH 9.6.

    Techniques: Enzyme-linked Immunosorbent Assay

    a Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following challenge of cynomolgus macaques ( n = 6/group) on day 176 by the SC route with 10 5 PFU of PRVABC59 wt-ZIKA strain. (ANOVA ** P -value < 0.01; *** P -value < 0.001). Dotted line = limit of quantification.

    Journal: NPJ Vaccines

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    doi: 10.1038/s41541-020-0167-8

    Figure Lengend Snippet: a Env-specific IgG ELISA titers, b ZIKV-specific microneutralization (MN 50 ) titers, and c NS1-specific IgG ELISA titers following challenge of cynomolgus macaques ( n = 6/group) on day 176 by the SC route with 10 5 PFU of PRVABC59 wt-ZIKA strain. (ANOVA ** P -value < 0.01; *** P -value < 0.001). Dotted line = limit of quantification.

    Article Snippet: Envelope- and NS1-specific IgGs were assessed by ELISA in 96-well plates coated with recombinant E protein (Meridian Life Science Inc., Memphis, USA) or recombinant non-structural protein 1 (NS1) protein (Native Antigen Company, Oxford, UK) in carbonate buffer, pH 9.6.

    Techniques: Enzyme-linked Immunosorbent Assay

    a prM/Env-specific memory B-cell ELISpot responses, b NS1-specific memory B-cell ELISpot responses at baseline, day 35 and day 112 following ZIKV challenge in cynomolgus macaques with 10 5 PFU of PRVABC59 wt-ZIKA strain. Bar = Geometric mean. (ANOVA * P -value < 0.05; ** P -value < 0.01; *** P -value < 0.001). Dotted line = responder cutoff. p.c. = post-challenge.

    Journal: NPJ Vaccines

    Article Title: An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques

    doi: 10.1038/s41541-020-0167-8

    Figure Lengend Snippet: a prM/Env-specific memory B-cell ELISpot responses, b NS1-specific memory B-cell ELISpot responses at baseline, day 35 and day 112 following ZIKV challenge in cynomolgus macaques with 10 5 PFU of PRVABC59 wt-ZIKA strain. Bar = Geometric mean. (ANOVA * P -value < 0.05; ** P -value < 0.01; *** P -value < 0.001). Dotted line = responder cutoff. p.c. = post-challenge.

    Article Snippet: Envelope- and NS1-specific IgGs were assessed by ELISA in 96-well plates coated with recombinant E protein (Meridian Life Science Inc., Memphis, USA) or recombinant non-structural protein 1 (NS1) protein (Native Antigen Company, Oxford, UK) in carbonate buffer, pH 9.6.

    Techniques: Enzyme-linked Immunospot